Page last updated: 2024-08-24

setoperone and mdl 100907

setoperone has been researched along with mdl 100907 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Chen, Z; Collier, T; Fu, H; Liang, SH; Rong, J; Zhou, J	1
Kapur, S; Mamo, D; Romach, MK; Sedman, E; Sellers, EM; Tillner, J	1

Reviews

1 review(s) available for setoperone and mdl 100907

Article	Year
Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors. Journal of medicinal chemistry, 2022, 08-25, Volume: 65, Issue:16 Topics: Brain; Humans; Ligands; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Serotonin	2022

Trials

1 trial(s) available for setoperone and mdl 100907

Article	Year
EMD 281014, a specific and potent 5HT2 antagonist in humans: a dose-finding PET study. Psychopharmacology, 2004, Volume: 175, Issue:3 Topics: Adult; Dose-Response Relationship, Drug; Female; Fluorine Radioisotopes; Frontal Lobe; Humans; Indoles; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Pyrimidinones; Radiopharmaceuticals; Receptors, Serotonin, 5-HT2; Serotonin 5-HT2 Receptor Antagonists	2004

Article

Year

EMD 281014, a specific and potent 5HT2 antagonist in humans: a dose-finding PET study.

Psychopharmacology, 2004, Volume: 175, Issue:3

Topics: Adult; Dose-Response Relationship, Drug; Female; Fluorine Radioisotopes; Frontal Lobe; Humans; Indoles; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Pyrimidinones; Radiopharmaceuticals; Receptors, Serotonin, 5-HT2; Serotonin 5-HT2 Receptor Antagonists

2004